Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 28.98
+1.42 (5.15%)
Sep 30, 2026, 4:08 PM HKT
HKG:3378 Market Cap
HKG:3378 has a market cap or net worth of 3.95 billion as of October 1, 2026.
Market Cap
3.95B
Enterprise Value
3.47B
Revenue
84.28K
Ranking
n/a
PE Ratio
n/a
Stock Price
28.98
ChartMarket Cap Chart
Since December 23, 2025, HKG:3378's market cap has increased from 2.34B to 3.95B, an increase of 68.49%. That is a compound annual growth rate of 96.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 3.95B | 81.35% |
| Dec 31, 2025 | 2.18B | -7.09% |
| Dec 23, 2025 | 2.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 5.24B |
| Jacobio Pharmaceuticals Group | 4.75B |
| TransThera Sciences (Nanjing) | 4.46B |
| Ocumension Therapeutics | 4.15B |
| Shanghai Bao Pharmaceuticals | 4.01B |
| Qyuns Therapeutics | 3.79B |
| Mirxes Holding Company | 3.66B |
| Laekna | 3.50B |